Cite
ROYAL, Richard E., LEVY, Catherine, TURNER, Keli, et al. Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. Journal of immunotherapy (Hagerstown, Md.: 1997), 2010, vol. 33, no 8, p. 828.
Royal, R. E., Levy, C., Turner, K., Mathur, A., Hughes, M., Kammula, U. S., ... & Rosenberg, S. A. (2010). Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. Journal of immunotherapy (Hagerstown, Md.: 1997), 33(8), 828.
Copy
Download .nbib